Bio-Techne Corporation (TECH)
NASDAQ: TECH · IEX Real-Time Price · USD
75.46
-0.46 (-0.61%)
At close: Jul 19, 2024, 4:00 PM
75.55
+0.09 (0.12%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Bio-Techne Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Bio-Techne stock have an average target of 81.11, with a low estimate of 65 and a high estimate of 95. The average target predicts an increase of 7.49% from the current stock price of 75.46.
Analyst Consensus: Buy
* Price targets were last updated on May 22, 2024.
Analyst Ratings
The average analyst rating for Bio-Techne stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $85 | Strong Buy → Hold | Downgrades | $85 | +12.64% | May 22, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +25.89% | May 2, 2024 |
| Baird | Baird | Buy Maintains $73 → $81 | Buy | Maintains | $73 → $81 | +7.34% | May 2, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $85 → $82 | Strong Buy | Maintains | $85 → $82 | +8.67% | Apr 18, 2024 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $65 | Strong Buy → Hold | Downgrades | $65 | -13.86% | Feb 2, 2024 |
Financial Forecast
Revenue This Year
1.18B
from 1.14B
Increased by 3.99%
Revenue Next Year
1.27B
from 1.18B
Increased by 7.70%
EPS This Year
1.82
from 1.76
Increased by 3.23%
EPS Next Year
2.07
from 1.82
Increased by 14.16%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.2B | 1.3B | 1.5B | 1.6B | 1.8B |
| Avg | 1.2B | 1.3B | 1.4B | 1.6B | 1.8B |
| Low | 1.1B | 1.2B | 1.3B | 1.5B | 1.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.5% | 12.1% | 17.0% | 15.8% | 17.7% |
| Avg | 4.0% | 7.7% | 10.5% | 10.7% | 14.4% |
| Low | -0.6% | 1.6% | 2.8% | 4.5% | 9.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.93 | 2.26 | 2.71 | 2.91 | 3.26 |
| Avg | 1.82 | 2.07 | 2.40 | 2.82 | 3.16 |
| Low | 1.71 | 1.82 | 2.11 | 2.70 | 3.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.8% | 24.2% | 30.6% | 21.1% | 15.6% |
| Avg | 3.2% | 14.2% | 15.8% | 17.2% | 12.3% |
| Low | -3.1% | 0.3% | 1.6% | 12.2% | 7.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.